Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Hippocampal markers of stress susceptibility identified

Dec. 1, 2011

Kyoto Pharmaceutical describes new indoline derivatives

Dec. 1, 2011

Selvita describes novel pim and haspin kinase inhibitors

Dec. 1, 2011

ADOPT study compares apixaban and enoxaparin in medically ill patients

Dec. 1, 2011

Ongoing trial investigates effects of bevacizumab in neoplastic meningitis

Nov. 30, 2011

Multi-biomarker panel may monitor clinical disease activity in subjects with RA

Nov. 30, 2011

Data presented from phase I trial of OPB-31121 in advanced solid malignancies

Nov. 30, 2011

Novartis discloses final results from EXIST-2 trial

Nov. 30, 2011

SK Biopharmaceuticals divulges preclinical data on SKL-A4R

Nov. 30, 2011

New inhibitor of dual specificity protein kinase TTK shows promising preclinical antitumor activity

Nov. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...